Amy R. Peck
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 8
- Cancer Cells and Metastasis 4
-
- interferon and immune responses 3
-
- Gene expression and cancer classification 4
- TGF-β signaling in diseases 3
- Single-cell and spatial transcriptomics 2
-
- Estrogen and related hormone effects 3
-
- Radiomics and Machine Learning in Medical Imaging 2
- Co-authors
- Hallgeir RuiChengbao LiuThai H. TranJ. Alan DiehlMelanie A. GirondoTerry HyslopSerge Y. FuchsJeffrey A. Hooke
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Amy R. Peck
23 papers receiving 761 citations
Peers
Comparison fields: 5 of 97
- Oncology 426
- Immunology 215
- Cancer Research 123
- Molecular Biology 349
- Endocrinology, Diabetes and Metabolism 68
Countries citing papers authored by Amy R. Peck
This map shows the geographic impact of Amy R. Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy R. Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy R. Peck more than expected).
Fields of papers citing papers by Amy R. Peck
This network shows the impact of papers produced by Amy R. Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy R. Peck. The network helps show where Amy R. Peck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy R. Peck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 15 | |
| 7 | Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer | 2022 | 15 |
| 8 | 2021 | 14 | |
| 9 | 2020 | 19 | |
| 10 | 2016 | 17 | |
| 11 | 2015 | 28 | |
| 12 | 2013 | 39 | |
| 13 | 2013 | 12 | |
| 14 | 2013 | 25 | |
| 15 | 2012 | 59 | |
| 16 | 2011 | 11 | |
| 17 | 2011 | 79 | |
| 18 | 2011 | 0 | |
| 19 | 2010 | 46 | |
| 20 | 2005 | 52 |
About Amy R. Peck
Amy R. Peck is a scholar working on Oncology, Cancer Research and Biophysics, having authored 26 papers that have together received 769 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Cancer Cells and Metastasis (4 papers), Gene expression and cancer classification (4 papers), interferon and immune responses (3 papers), TGF-β signaling in diseases (3 papers), Estrogen and related hormone effects (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Oncology (426 citations), Immunology (215 citations) and Cancer Research (123 citations). Amy R. Peck has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Hallgeir Rui, Chengbao Liu, Thai H. Tran, J. Alan Diehl, Melanie A. Girondo, Terry Hyslop, Serge Y. Fuchs, Jeffrey A. Hooke, Albert J. Kovatich and Craig D. Shriver.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.